Cargando…
The high expression of glial cell line-derived neurotrophic factor receptor alpha Ⅱ (GFRA2) as a predictor of poor prognosis in gastric cancer patients: A survival and regression analysis approach
Gastric cancer has high mortality rates worldwide. Therefore, there is a need to identify prognostic biomarkers. This study evaluated the association between GFRA2 expression levels with clinicopathological features and prognosis in gastric cancer using data extracted from The Cancer Genome Atlas (T...
Autores principales: | Yang, Shaoyu, Li, Juan, Cai, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372394/ https://www.ncbi.nlm.nih.gov/pubmed/37519699 http://dx.doi.org/10.1016/j.heliyon.2023.e18291 |
Ejemplares similares
-
GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer
por: Eftang, Lars Lohne, et al.
Publicado: (2016) -
The Non-Survival Effects of Glial Cell Line-Derived Neurotrophic Factor on Neural Cells
por: Cortés, Daniel, et al.
Publicado: (2017) -
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: He, Rongfang, et al.
Publicado: (2017) -
The Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family Receptor Alpha (GFRα) in Cancers
por: Li, Qingshang, et al.
Publicado: (2022) -
Intracellular Neuroprotective Mechanisms in Neuron-Glial Networks Mediated by Glial Cell Line-Derived Neurotrophic Factor
por: Mitroshina, Еlena V., et al.
Publicado: (2019)